Revenue
2023
2024
2025
2026
Autonomix Medical, Inc. (AMIX)
Price—Loading quote
Net income
2023
2024
2025
2026
Free cash flow
2023
2024
2025
2026
Total cash / debt
CashTotal debt
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Research & development | $7.1M | $4.7M | $2.2M | $745,000 |
| Operating expenses | $17.0M | $11.6M | $12.0M | $2.0M |
| Operating income | −$17.0M | −$11.6M | −$12.0M | −$2.0M |
| EBITDAderived | −$17.0M | −$11.4M | −$11.9M | −$2.0M |
| Net income | −$16.7M | −$11.4M | −$15.4M | −$2.0M |
| Basic EPSper diluted share | -$2.32 | -$6.46 | -$14.82 | -$0.17 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 18, 2024Form 4 | Robins David AndrewDirector | BuyWarrant (Right to buy) · derivative · indirect | 104.0K | $0.00 | $0.00 | 110.2K |